Funding Details
- Date Award
- May 13, 2024
- Vertical
- Therapeutics
- Funding URL
- View Funding Page
Company Info
- Founders
- Jelena Vulevic, George Tzortzis
- Company Description
- We address modern lifestyle diseases and conditions without the need to change person’s lifestyle, with a novel and unique technology that mimics the communication skills of certain beneficial members of the gut microbiome. We integrate sequencing/informatics technologies and synthetic biology to identify and advance promising molecules encoded in gut microbial DNA. Our developing platform allows us to identify, characterize and prioritize naturally occurring molecules for nutraceuticals application and further redesign them in silico providing practical access to numerous new potential drugs. Our aim is to create sustainable, cost effective and widely available therapies that improve sufferers’ outcomes.
- Market
- Nutrition & Wellness
- Location
-
United Kingdom
Links